<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boyapati RK</submitter><funding>Medical Research Society UK</funding><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><funding>Crohn's and Colitis UK</funding><funding>MRC</funding><pagination>2113-2122</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7301773</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Due to common evolutionary origins, mitochondrial DNA (mtDNA) shares many similarities with immunogenic bacterial DNA. MtDNA is recognized as a pro-inflammatory damage-associated molecular pattern (DAMP) with a pathogenic role in several inflammatory diseases. We hypothesised that mtDNA is released during active disease, serving as a key pro-inflammatory factor in inflammatory bowel disease (IBD).&lt;h4>Methods&lt;/h4>Between 2014 and 2015, we collected plasma separated within 2 hours of sampling from 97 prospectively recruited IBD patients (67 ulcerative colitis [UC] and 30 Crohn's disease [CD]) and 40 non-IBD controls. We measured circulating mtDNA using quantitative polymerase chain reaction (amplifying mitochondria COXIII/ND2 genes) and also in mouse colitis induced by dex</pubmed_abstract><journal>Inflammatory bowel diseases</journal><pubmed_title>Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD.</pubmed_title><pmcid>PMC7301773</pmcid><funding_grant_id>M16-1</funding_grant_id><funding_grant_id>WT096497</funding_grant_id><funding_grant_id>Vac-982-2016</funding_grant_id><funding_grant_id>G0701898</funding_grant_id><pubmed_authors>Kalla R</pubmed_authors><pubmed_authors>Satsangi J</pubmed_authors><pubmed_authors>Tamborska A</pubmed_authors><pubmed_authors>Loane J</pubmed_authors><pubmed_authors>Boyapati RK</pubmed_authors><pubmed_authors>Ventham NT</pubmed_authors><pubmed_authors>Gray M</pubmed_authors><pubmed_authors>Rossi AG</pubmed_authors><pubmed_authors>Dorward DA</pubmed_authors><pubmed_authors>Doherty MK</pubmed_authors><pubmed_authors>Whitfield PD</pubmed_authors><pubmed_authors>Ho GT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD.</name><description>&lt;h4>Background&lt;/h4>Due to common evolutionary origins, mitochondrial DNA (mtDNA) shares many similarities with immunogenic bacterial DNA. MtDNA is recognized as a pro-inflammatory damage-associated molecular pattern (DAMP) with a pathogenic role in several inflammatory diseases. We hypothesised that mtDNA is released during active disease, serving as a key pro-inflammatory factor in inflammatory bowel disease (IBD).&lt;h4>Methods&lt;/h4>Between 2014 and 2015, we collected plasma separated within 2 hours of sampling from 97 prospectively recruited IBD patients (67 ulcerative colitis [UC] and 30 Crohn's disease [CD]) and 40 non-IBD controls. We measured circulating mtDNA using quantitative polymerase chain reaction (amplifying mitochondria COXIII/ND2 genes) and also in mouse colitis induced by dex</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Sep</publication><modification>2025-05-29T21:04:01.678Z</modification><creation>2025-05-29T21:04:01.678Z</creation></dates><accession>S-EPMC7301773</accession><cross_references><pubmed>29718255</pubmed><doi>10.1093/ibd/izy095</doi></cross_references></HashMap>